Actively Recruiting
Clinical and Molecular Manifestations of Inherited Neurological Disorders
Led by National Institute of Neurological Disorders and Stroke (NINDS) · Updated on 2026-04-14
3500
Participants Needed
2
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying the natural history and genetic basis of inherited neurological disorders, including hereditary peripheral neuropathies, myopathies, muscular dystrophies, motor neuron disorders, mitochondrial myopathies, neurocognitive disorders, and others. This observational study aims to better understand these rare and complex diseases by examining symptoms, disease progression, treatment effects, and psychological and behavioral impacts across a broad range of inherited neurological conditions. Participants include children and adults with diagnosed or suspected inherited neurological diseases, as well as their unaffected relatives. They will undergo detailed medical and family history reviews, physical and neurological exams, and may have blood, urine, or genetic testing, along with brain wave recordings and psychological evaluations. Imaging tests and muscle or nerve testing may also be performed based on individual symptoms. Samples such as blood or skin biopsies may be collected for genetic analysis. Throughout the study, participants will be evaluated with various assessments including neurological exams, psychological tests, and possibly imaging scans. Researchers will track genetic disease identification and deep phenotyping of rare neurological disorders. The study aims to collect data over a long duration to enhance understanding, diagnosis, and future research. Participants may also contribute samples for laboratory studies, and the study supports training of fellows and students. The total enrollment is planned for up to 3,500 participants and their relatives, with ongoing follow-up until genetic diagnoses are made.
CONDITIONS
Brief Title
Study of Inherited Neurological Disorders
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Have a known or suspected inherited neurological disease, or be an unaffected relative of a participant with a genetic neurological disease
- Ability to understand and sign informed consent or have a parent/legal guardian provide consent
- Aged 2 years and above
You will not qualify if you...
- Have a systemic disease that prevents an adequate neurological examination or diagnosis, such as a contagious disease that compromises examination
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Initial visit and ongoing until a genetic diagnosis is made, up to 15 years
Participants undergo clinical assessments and provide biological samples to evaluate and diagnose inherited neurological disorders.
1 initial visit with possible additional visits for assessments and sample collection
Trial Site Locations
Total: 2 locations
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892
Actively Recruiting
2
University of Mali
Bamako, Mali
Completed
Research Team
A
Alice B Schindler
C
Christopher Grunseich, M.D.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here